Políticas Médicas

Las políticas médicas son documentos que definen el reconocimiento de cubierta para tecnologías, procedimientos y tratamientos. Las declaraciones de necesidad médica en las políticas, sobre si una tecnología, procedimiento, tratamiento, suplido, equipo, medicamento u otro servicio mejora el resultado en la salud de la población para la cual dicha tecnología o tratamiento fue diseñado se basan en evidencia científica, estudios clínicos y opiniones profesionales de nuestros proveedores y de las organizaciones médicas reconocidas.

Cada documento desplegado en este sitio Web se provee con propósitos informativos solamente y no es una autorización, explicación de beneficios o un contrato. El recibir beneficios está sujeto a la satisfacción de todos los términos y condiciones de la cubierta. La tecnología médica cambia constantemente y nos reservamos el derecho de revisar y actualizar nuestras políticas periódicamente.

Tabla de Políticas Médicas

ID Título Revisión Descripción Acceso
11.003.053 Whole Exome And Whole Genome Sequencing For Diagnosis Of Genetic Disorders Feb 2026 Whole exome sequencing (wes) sequences the portion of the genome that contains protein-coding dna, while... Ver
11.003.056 Genetic Testing For A Thalassemia Jul 2025 Alpha-thalassemia represents a group of clinical syndromes of varying severity characterized by hemolytic... Ver
11.003.057 Genetic Testing For Fanconi Anemia Jan 2026 Fanconi anemia (fa) is an inherited disorder characterized by congenital abnormalities, bone marrow failure,... Ver
11.003.059 Genetic Testing For Hereditary Pancreatitis Mar 2026 ... Ver
11.003.060 Genetic Testing For Flt3, Npm1, And Cebpa Variants In Cytogenetically Normal Acute Myeloid Leukemia Feb 2026 Treatment of acute myeloid leukemia (aml) is based on risk stratification, primarily related to age and tumor... Ver
11.003.061 Genotipado de Nucleótido único 9p21-polimorfismos de Predecir el Riesgo Oct 2016 ... Ver
11.003.062 General Approach To Genetic Testing Jan 2026 Commercially available genetic tests can perform a host of functions, such as providing a guided intervention... Ver
11.003.063 Bcr-Abl1 Testing In Chronic Myelogenous Leukjemia And Acute Lymphoblastic Leukemia Nov 2025 In the treatment of philadelphia chromosome-positive leukemias, various nucleic acid-based laboratory methods... Ver
11.003.064 Genetic Cancer Susceptibility Panels Using Next Generation Sequencing Feb 2026 Commercially available cancer susceptibility gene panels can test for multiple variants associated with a... Ver
11.003.066 Genetic Testing For Duchenne And Becker Muscular Dystrophy Apr 2026 Variants in the duchenne muscular dystrophy (dmd) gene, which encodes the protein dystrophin, may result in a... Ver
11.003.067 Genotype-Guided Warfarin Dosing Jul 2025 Using information about an individual's genotype may help in guiding warfarin dosing and could reduce... Ver
11.003.068 Genetic Testing For The Diagnosis Of Inherited Peripheral Neuropathies Feb 2026 The inherited peripheral neuropathies are a heterogeneous group of diseases that may be inherited in an... Ver
11.003.069 Analysis Of Mgmt Promoter Methylation In Malignant Gliomas Jun 2019 Testing for o6-methylguanine-dna methyltransferase (mgmt) gene promoter methylation has been proposed as a... Ver
11.003.070 Preimplantation Genetic Testing Sep 2025 Preimplantation genetic testing involves the analysis of biopsied cells as part of an assisted reproductive... Ver
11.003.072 Genetic Testing For Marfan Syndrome, Thoracic Aortic Aneurysms And Dissections, And Related Disorders Mar 2026 Marfan syndrome (mfs) is a systemic connective tissue disease (ctd) with a high degree of clinical... Ver
11.003.073 Laboratory And Genetic Testing For Use Of 5-Fluorouracil In Patients With Cancer Apr 2025 Variability in systemic exposure to 5-fluorouracil chemotherapy is thought to directly impact 5-fluorouracil... Ver
11.003.075 Proteomic Testing For Targeted Therapy In Non-Small-Cell Lung Cancer Dec 2025 Proteomic testing has been proposed as a way to predict survival outcomes, as well as the response to and... Ver
11.003.076 Multibiomarker Disease Activity Blood Test For Rheumatoid Arthritis Jul 2025 Assessment of disease activity in rheumatoid arthritis (ra) is an important component of management with a... Ver
11.003.077 Los ensayos de varios analitos con el análisis algorítmico para predecir el ries Oct 2016 ... Ver
11.003.078 Noninvasive Prenatal Screening For Fetal Aneuploidies And Microdeletions Using Cell-Free Fetal Dna Apr 2026 ... Ver